Find and Pitch Jounalists, Get Your Story Covered

Tags: cervical cancer sickle cell breast cancer breast cancer screening COVID

	Profile	Recent Articles on Subject
1	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study - 5 days ago STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 6 days ago STAT+: Results on Novartis prostate cancer therapy could expand its use - 11 months ago STAT+: Roche drug slashes recurrence, death risk in lung cancer that afflicts younger patients - 11 months ago STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial - 12 months ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 5 days ago HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer - 5 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 5 months ago PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening - 6 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 8 months ago Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone - 8 months ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - 8 months ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - 9 months ago TULSA Effective in Controlling Prostate Cancer Long-Term - 10 months ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - 10 months ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - 10 months ago Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer - 10 months ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - 11 months ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - 11 months ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - 11 months ago
3	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 days ago Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC With Adagrasib - 6 months ago
4	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 4 months ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novartis Pays $150M to Nab a Phase 3-Ready Protein Degrader for Prostate Cancer - 5 months ago
6	AFP Science Alert Science news. Official account. Australia science news	Scientists Predict Prostate Cancer Cases to Double Within 20 Years - 6 months ago
7	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Study Tests Office-Based Transperineal Approach to Prostate Biopsies - 7 months ago Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC - 7 months ago Novel Prostate Cancer Screening Method Could Prevent Unnecessary Biopsies - 7 months ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - 9 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - 9 months ago
8	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - 8 months ago New Capivasertib Approval Benefits Patients With Breast Cancer, PIK3CA/AKT1/PTEN Alterations - 10 months ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Treatments - 10 months ago
9	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	Zelix Pharmaceuticals Files BLA for PET Imaging Agent for Renal Cell Carcinoma - 9 months ago FDA Grants Fast Track, Breakthrough Designations to CG Oncology Inc’s Cretostimogene Grenadenorepvec - 9 months ago Xtandi Approved by FDA for Nonmetastatic Castration-Sensitive Prostate Cancer - 10 months ago FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer - 10 months ago FDA Approves Keytruda Plus Chemotherapy for Biliary Tract Cancer - 11 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - 9 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 9 months ago FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer - 10 months ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - 12 months ago

Journalists covering castrate-resistant prostate cancer